Renal Transplant Recipients

• CLINICAL_TRIALS trial_result · 2022-06-02
  Clinical Trial Update: CNS Study of Patients Switching From Tacrolimus to Envarsus [Phase 4]

  Phase 4 trial update on switching renal transplant patients from tacrolimus to Envarsus; results have been posted.

• CLINICAL_TRIALS trial_result · 2022-02-09
  Clinical Trial Update: The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients [Phase 2]

  Phase 2 trial evaluating the effect of enalapril, losartan, or no antihypertensive therapy on oxidative stress in renal transplant recipient…

• CLINICAL_TRIALS trial_result · 2020-03-24
  Clinical Trial Update: Envarsus XR in African American Renal Transplant Recipients [NA]

  A terminated clinical trial update for Envarsus XR in African American renal transplant recipients with posted results.

• CLINICAL_TRIALS trial_result · 2019-05-31
  Clinical Trial Update: Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients [Phase 3]

  Phase 3 trial in paediatric renal transplant recipients evaluating early everolimus with reduced calcineurin inhibitors and early steroid el…

• CLINICAL_TRIALS trial_result · 2017-10-04
  Clinical Trial Update: Research Study of ATG and Rituximab in Renal Transplantation [EARLY_Phase 1]

  Early-phase trial investigating ATG and Rituximab in renal transplant recipients was terminated; results posted in 2017.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2006-05-18
  Clinical Trial Update: Web Based Renal Transplant Patient Medication Education [Phase 4]

  Phase 4 trial evaluating a web-based education program for renal transplant recipients' medication management; current status is unknown.